- Home
- CISS vs NUWE Comparison
CISS vs NUWE Comparison
Compare CISS & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CISS | NUWE |
|---|---|---|
| Founded | 2022 | 1999 |
| Country | Greece | United States |
| Employees | N/A | 38 |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | CISS | NUWE |
|---|---|---|
| Price | $2.08 | $0.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.3M | ★ 2.8M |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $11.14 |
| Revenue Next Year | N/A | $18.51 |
| P/E Ratio | $0.82 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.08 | $0.13 |
| 52 Week High | $6.06 | $25.95 |
Technical Indicators
Market Signals| Indicator | CISS | NUWE |
|---|---|---|
| Relative Strength Index (RSI) | 43.18 | 12.86 |
| Support Level | $2.00 | N/A |
| Resistance Level | $2.23 | $1.20 |
| Average True Range (ATR) | 0.23 | 0.09 |
| MACD | -0.05 | -0.05 |
| Stochastic Oscillator | 38.82 | 1.14 |
Price Performance
Historical ComparisonAbout CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.